APA citáció

Boér Katalin, Kahán Zsuzsanna, Landherr László, Csőszi Tibor, Máhr Károly, Ruzsa Ágnes, . . . Rubovszky Gábor. (2021). Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.

Chicago Style (17th ed.) Citation

Boér Katalin, Kahán Zsuzsanna, Landherr László, Csőszi Tibor, Máhr Károly, Ruzsa Ágnes, Horváth Zsolt, Budai Barna, and Rubovszky Gábor. Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience. 2021.

MLA idézés

Boér Katalin, et al. Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience. 2021.